首页> 外文OA文献 >Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors

【2h】

Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors

机译：通过质谱癌患者检测来自肺癌患者的血浆DNA中的EGFR突变是预测肿瘤EGFR状态和对EGFR抑制剂的反应

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Marie Brevet; Melissa L. Johnson; Christopher G. Azzoli; Marc Ladanyi;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors. [J] . Brevet M, Johnson ML, Azzoli CG, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2011,第1期

机译：通过质谱基因分型法检测肺癌患者血浆DNA中的EGFR突变可预测肿瘤EGFR的状态以及对EGFR抑制剂的反应。
2. The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations [J] . Akihiro Yoshimura, Tadaaki Yamada, Naoko Okura, BMC Cancer . 2018,第1期

机译：初始EGFR抑制剂的影响根据患有EGFR突变的非小细胞肺癌患者EGFR-T790M突变的检测
3. EGFR mutation status in plasma and tumor tissues in non-small cell lung cancer serves as a predictor of response to EGFR-TKI treatment [J] . Que Dan, Xiao He, Zhao Baojian, Cancer biology & therapy . 2016,第3期

机译：非小细胞肺癌血浆和肿瘤组织中的EGFR突变状态可作为对EGFR-TKI治疗反应的预测指标
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Mutation profiling in colorectal cancer patients with microsatellite instability; High frequency of BRCA2 and EGFR somatic mutations [D] . Deihimi, Safoora. 2016

机译：具有微卫星不稳定性的大肠癌患者的突变谱； BRCA2和EGFR体细胞突变的频率高
6. Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors [O] . Marie Brevet, Melissa L. Johnson, Christopher G. Azzoli, -1

机译：通过质谱癌患者检测来自肺癌患者的血浆DNA中的EGFR突变是预测肿瘤EGFR状态和对EGFR抑制剂的反应
7. The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations [O] . Akihiro Yoshimura, Tadaaki Yamada, Naoko Okura, 2018

机译：初始EGFR抑制剂的影响根据患有EGFR突变的非小细胞肺癌患者EGFR-T790M突变的检测

Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors

著录项

引文网络

相似文献

相关主题

期刊订阅